Windham, NH, United States of America

Jianxun Zhou

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Calixa Therapeutics, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianxun Zhou. Retrieved from https://idiyas.com/inventor/jianxun-zhou-fxwctfex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jianxun Zhou

Introduction

Jianxun Zhou is a notable inventor based in Windham, NH (US). He has made significant contributions to the field of pharmaceuticals, particularly in antibiotic compositions. His work has led to advancements that are crucial in combating bacterial infections.

Latest Patents

Jianxun Zhou holds 1 patent for his invention related to Ceftolozane antibiotic compositions. This patent provides pharmaceutical compositions comprising ceftolozane, as well as combinations with tazobactam. The methods of preparing these compositions and their related uses are also detailed in his patent.

Career Highlights

Zhou is currently associated with Calixa Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in antibiotic development is instrumental in the company's mission to create effective treatments for resistant bacterial infections.

Collaborations

Throughout his career, Jianxun Zhou has collaborated with talented professionals such as Joseph Terracciano and Nicole Miller Damour. These partnerships have enhanced the research and development efforts at Calixa Therapeutics, Inc.

Conclusion

Jianxun Zhou's contributions to antibiotic compositions exemplify the importance of innovation in healthcare. His work not only advances scientific knowledge but also plays a vital role in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…